This initiative, conducted at the Arthritis Center at Brigham and Women’s Hospital, had three distinct but related steps:

  1. Development of an internally endorsed treatment pathway.
  2. Detailed retrospective Chart reviews.
  3. Improved documentation of functional status and disease activity measures.

Citation for the Full-text Article

Dave AJ, Tory HO, Awosogba JA, Coblyn JS, Bermas B, Solomon DH, Desai SP. A quality improvement approach to rheumatoid Arthritis management with biologic disease-modifying antirheumatic drugs: assessing variability in a treatment pathway. J Clin Rheumatol. 2017 Jan;23(1):66-69. doi: 10.1097/RHU.0000000000000474.

Latest News from CRICO

Get all your medmal and patient safety news here.
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.